Document Detail


Involvement of ligand occupancy in Insulin-like growth factor-I (IGF-I) induced cell growth in osteoblast like MC3T3-E1 cells.
MedLine Citation:
PMID:  18057550     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Growth factors and matrix proteins regulate the proliferation and differentiation of osteoblasts. The insulin-like growth factor (IGF) system comprises IGF-I, IGF-II, and six high-affinity IGF-binding proteins (IGFBPs). IGFs stimulate cell growth in many types of tissue; IGF-binding proteins regulate cellular actions and can affect cell growth. IGF-I is involved in differentiation, proliferation, and matrix formation in osteoblasts; IGFBP-5 is associated with the extracellular matrix (ECM) and can potentiate the actions of IGF-I. We investigated the effect of ECM proteins on the responses of MC3T3-E1 osteoblast cells to IGF-I and IGFBP-5. In addition, because extracellular signal-regulated kinases 1 and 2 (Erk 1/2) affect cell growth, we evaluated the effects of IGFBP-5 on Erk 1/2 phosphorylation in MC3T3-E1 cells. IGF-I caused an increase in IGFBP-5 expression in cultured MC3T3-E1 cells, and IGF-I plus IGFBP-5 significantly increased cell growth. Likewise, the addition of IGF-I and IGFBP-5 to cultured MC3T3-E1 cells increased the synthesis of the ECM proteins osteopontin (OPN) and thrombospondin-1 (TSP-1), which can bind to alphaVbeta3 integrin receptors on the cell surface. By contrast, the addition of an antibody against ECM proteins inhibited the effects of OPN and TSP-1 on IGFBP-5 expression. The stimulatory effect of IGFBP-5 was mediated via Erk 1/2 activation. These data suggest that IGFBP-5 regulates Erk 1/2 phosphorylation in cultured MC3T3-E1 cells via ECM proteins that may ultimately stimulate the growth of osteoblasts. We determined whether occupation of the alphaVbeta3 integrin receptor affects IGF-I receptor (IGF-IR)-mediated signaling and function in MC3T3-E1 osteoblast cells. Occupation of the alphaVbeta3 integrin receptor with ECM proteins induced IGF-I-stimulated IGF-IR phosphorylation. Conversely, in the presence of the alphaVbeta3-specific disintegrin echistatin, IGF-I-stimulated IGF-IR activation was inhibited. IGF-I-stimulated IGF-IR phosphorylation was accompanied by IRS-1 phosphorylation and MAPK activation. However, these effects were attenuated by echistatin. Thus, occupancy of the alphaVbeta3 disintegrin receptor modulates IGF-I-induced IGF-IR activation and IGF-IR-mediated function in MC 3T3-E1 osteoblasts.
Authors:
Seok-Kwun Kim; Ji-Young Kwon; Taek-Jeong Nam
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  BioFactors (Oxford, England)     Volume:  29     ISSN:  0951-6433     ISO Abbreviation:  Biofactors     Publication Date:  2007  
Date Detail:
Created Date:  2007-12-06     Completed Date:  2008-04-14     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  8807441     Medline TA:  Biofactors     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  187-202     Citation Subset:  IM    
Affiliation:
Department of Plastic and Reconstructive Surgery, College of Medicine, Dong-A University, Seo-Gu, Busan, South Korea. sgkim1@daunet.donga.ac.kr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
3T3 Cells
Animals
Binding Sites / drug effects
Blotting, Northern
Blotting, Western
Cell Line
Cell Movement / drug effects
Cell Proliferation / drug effects*
Cells, Cultured
Extracellular Matrix / drug effects
Extracellular Signal-Regulated MAP Kinases / drug effects,  metabolism
Humans
Insulin-Like Growth Factor Binding Protein 5 / biosynthesis,  pharmacology*
Insulin-Like Growth Factor I / pharmacology*
Integrin alphaVbeta3 / antagonists & inhibitors,  drug effects,  metabolism
Ligands
Mice
Osteoblasts / drug effects*,  metabolism
Osteopontin / metabolism
Peptides / pharmacology
Phosphorylation / drug effects
Protein Binding / drug effects
Signal Transduction / drug effects
Thrombospondin 1 / metabolism
Chemical
Reg. No./Substance:
0/Insulin-Like Growth Factor Binding Protein 5; 0/Integrin alphaVbeta3; 0/Ligands; 0/Peptides; 0/Thrombospondin 1; 106441-73-0/Osteopontin; 118337-11-4/echistatin; 67763-96-6/Insulin-Like Growth Factor I; EC 2.7.11.24/Extracellular Signal-Regulated MAP Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A combination of soy isoflavone supplementation and exercise improves lipid profiles and protects an...
Next Document:  Diabetes, metallothionein, and zinc interactions: a review.